A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
Clinical trial NCT06993116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06993116
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2027-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.